Journey Medical (DERM) Research & Development (2021 - 2025)
Historic Research & Development for Journey Medical (DERM) over the last 5 years, with Q3 2025 value amounting to $287000.0.
- Journey Medical's Research & Development fell 6591.45% to $287000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $544000.0, marking a year-over-year decrease of 9511.84%. This contributed to the annual value of $9.9 million for FY2024, which is 3071.21% up from last year.
- According to the latest figures from Q3 2025, Journey Medical's Research & Development is $287000.0, which was down 6591.45% from $39000.0 recorded in Q1 2025.
- Over the past 5 years, Journey Medical's Research & Development peaked at $7.9 million during Q1 2024, and registered a low of $29000.0 during Q2 2021.
- For the 5-year period, Journey Medical's Research & Development averaged around $1.8 million, with its median value being $1.5 million (2023).
- In the last 5 years, Journey Medical's Research & Development soared by 889655.17% in 2022 and then tumbled by 9950.53% in 2025.
- Journey Medical's Research & Development (Quarter) stood at $2.0 million in 2021, then surged by 113.65% to $4.3 million in 2022, then tumbled by 64.64% to $1.5 million in 2023, then tumbled by 85.51% to $218000.0 in 2024, then soared by 31.65% to $287000.0 in 2025.
- Its last three reported values are $287000.0 in Q3 2025, $39000.0 for Q1 2025, and $218000.0 during Q4 2024.